Pharmacists are divided over provisions in the House and Senate health care reform bills, but most agree on the need to expand medication therapy management services, reduce patient readmissions, and provide access to discounted drugs.
You are here
P&T® Journal contents for March 2010
Industry’s Agenda Is Clear, but Its Future Path Is Not
Rituximab prolongs survival in patients with aggressive lymphomas, but more study is needed to clarify its effect on survival of patients with indolent lymphomas.
Representative studies focus on aromatase inhibitors, tamoxifen, and bisphosphonates. Agents for pancreatic, colorectal, and gastric cancers are also reviewed.
Topics include agents for multiple sclerosis, rheumatoid arthritis, and hypertension.
Continuing Education Credit
Applying the 2010 Joint Commission Patient Safety Goal Requirements
Ensuring continuity of care for patients needing erythrocyte-stimulating agents helps to prevent hemoglobin fluctuations, avoids duplications, and lowers hospital costs.